Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
about
Proteomic analysis reveals that proteasome subunit beta 6 is involved in hypoxia-induced pulmonary vascular remodeling in ratsLong-term respiratory health effects in textile workersUpper limb exercise training for COPDNeuromuscular electrostimulation for chronic obstructive pulmonary diseaseValidation of chronic obstructive pulmonary disease (COPD) diagnoses in healthcare databases: a systematic review protocolTai Chi for chronic obstructive pulmonary disease (COPD)Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)Involvement of informal caregivers in supporting patients with COPD: a review of intervention studiesCOPD and exercise: does it make a difference?Brazilian studies on pulmonary function in COPD patients: what are the gaps?Epithelial Anion Transport as Modulator of Chemokine SignalingCOPD and stroke: are systemic inflammation and oxidative stress the missing links?Pulmonary vasculature in COPD: The silent componentYear in review 2015: Asthma and chronic obstructive pulmonary diseaseCachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspectiveInnovations in health information technologies for chronic pulmonary diseasesMeditative Movement as a Treatment for Pulmonary Dysfunction in Flight Attendants Exposed to Second-Hand Cigarette Smoke: Study Protocol for a Randomized Trial.Exacerbations of COPDDifferential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterolA rational approach to single, dual and triple therapy in COPDCandidate genes for COPD: current evidence and researchChanging physical activity and sedentary behaviour in people with COPDPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDEndoscopic bronchial valve treatment: patient selection and special considerationsGlobal burden of COPDThe relationship between COPD and lung cancerTargeted anti-inflammatory therapeutics in asthma and chronic obstructive lung diseaseThis is what COPD looks likePositioning new pharmacotherapies for COPDSirtuin 1 and aging theory for chronic obstructive pulmonary diseaseClinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of lifeClinical characteristics of the asthma-COPD overlap syndrome--a systematic reviewProfile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPDPneumococcal vaccine and patients with pulmonary diseasesGait speed as a measure of functional status in COPD patientsHealth and social impacts of COPD and the problem of under-diagnosisChronic obstructive pulmonary disease: respiratory review of 2013Clinical issues of mucus accumulation in COPDBiomarkers of progression of chronic obstructive pulmonary disease (COPD)
P2860
Q21132996-DA75EA7E-99C8-4385-B2D0-F8636A6EE980Q23919375-32304443-8252-49E3-A9F6-AEED9ED03ACFQ24187580-944C7828-D325-44CD-8CE6-499A6EC4CA39Q24202638-768F1E24-8BB4-4FAA-83B7-154187BB1C94Q24658536-81CD3C68-5E7D-4D8F-BE5D-183D90FCDEACQ26471513-FFE9EAB7-A92E-4BD4-BC3D-2133F224ED21Q26738321-73271461-38AA-4F76-8006-7E3D666DBAC6Q26740215-38622938-8067-45AD-BCF4-A4A734289921Q26740396-29D135F8-3D9B-47DD-A120-D85D38C987EAQ26740768-326E087F-9D7D-461C-AE6A-6EAEE9E4086AQ26741168-A1357338-907F-4F3A-A455-5477B70C7192Q26744381-9B4CF49B-E79E-4B94-8EFE-70B7F46AA30BQ26746530-CBDEBB85-0145-49FE-A6C9-D9AE073B842CQ26749309-B331FC9F-E242-4942-86C9-B6D83A1FB87DQ26749314-B13A1E43-A5D6-4E3F-BE90-AC40A17C3BC0Q26749418-80A1DCE7-7FAB-4BAE-8A1A-769454346584Q26751436-5F567493-030B-4735-A94B-D95FDDA72E28Q26752376-81BC0204-075C-4E3F-843E-288137EEC51DQ26764891-B496052A-0DBA-4803-8662-704062E25082Q26775244-DC69027F-A14E-4867-B7CE-5145158B1125Q26776477-D6FF4982-22F1-462A-AFD4-CA48502478DDQ26777324-B3824186-39D7-48E0-AF6F-B91498B6F61DQ26777465-36BA937C-C70A-4693-BD8C-4B0DF059EF0EQ26778685-536E75EA-4B71-4CDE-9BC5-A4E7AB50F794Q26778692-2AEDC8C0-C39C-43D0-A7E5-F4A85992E5A7Q26780363-3465BFA9-2FF4-44FF-B342-1FF27DB8F410Q26781337-778BF447-4DFE-49BD-81EB-900F12A3D3AAQ26786229-ABC9FC02-C239-46E3-8F4A-8E3218B0F082Q26786445-792ACF52-93A0-41D9-8964-DB3B0CB2F287Q26798659-343D5D3E-438C-4DCB-A205-52A1579E9186Q26799889-3981FE56-C6F8-4057-9852-E8587DEAD9F5Q26801134-2661990B-47E1-474E-82DD-7C743B0C2BFBQ26801310-7ACF8B18-BE00-49AA-A242-5875348BA887Q26825822-4C2072CF-D8D6-4C5F-8E6E-FEA601E49ECFQ26825944-D42E0785-0E68-4B38-9402-A1C43019D5D0Q26861187-3CE81763-6B4E-49F0-9D28-D9142126CA3DQ26864108-0953B34B-0BA4-4EF3-A154-959FF500485EQ26864703-0462B867-88D0-4D70-9A9D-423CBB8A6940Q26992257-C47993B9-B0F2-47C3-BFF2-4F058E7ACAB7Q26996356-85F1BA22-C83C-4E03-85ED-E80ECE9E0C5D
P2860
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Global strategy for the diagno ...... isease: GOLD executive summary
@ast
Global strategy for the diagno ...... isease: GOLD executive summary
@en
type
label
Global strategy for the diagno ...... isease: GOLD executive summary
@ast
Global strategy for the diagno ...... isease: GOLD executive summary
@en
prefLabel
Global strategy for the diagno ...... isease: GOLD executive summary
@ast
Global strategy for the diagno ...... isease: GOLD executive summary
@en
P2093
P3181
P1476
Global strategy for the diagno ...... isease: GOLD executive summary
@en
P2093
Martinez FJ
Nishimura M
Rodriguez-Roisin R
P304
P3181
P356
10.1164/RCCM.201204-0596PP
P407
P577
2013-02-15T00:00:00Z